KRRO- Korro Bio, Inc.

Name: Korro Bio, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Korro Bio, Inc. (KRRO) has 17 insiders with recent SEC Form 4 filings, including 4 buys and 7 sells. KRRO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Lynx1 Capital Management LP	1.54M	$19.98M	-
10%	Makhzoumi Mohamad	1.30M	$16.86M	-
10%	New Enterprise Associates 17, L.P.	1.30M	$16.86M	-
10%	Yang Rick	1.30M	$16.86M	-
10%	Sandell Scott D	1.30M	$16.86M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 16, 2026	Vincent Loic A	Chief Scientific Officer	Sell	3,418	$10.83	$37,016.94	-15.7%	-	-
Jun 16, 2026	Dolan Oliver	Senior Vice President, Finance	Sell	3,383	$10.83	$36,637.89	-15.7%	-	-
Jun 16, 2026	Chappell Todd	Chief Operating Officer	Sell	3,168	$10.83	$34,309.44	-15.7%	-	-
Jun 16, 2026	Cerio Jeffrey	General Counsel	Sell	6,609	$10.83	$71,575.47	-15.8%	-	-
May 29, 2026	Aiyar Ram	President And CEO	Sell	15,152	$12.98	$196,672.96	-16.8%	-	-
May 28, 2026	Formela Jean Francois70	Director	Sell	2,860	$13.95	$39,897.00	-0.3%	-	-
Mar 31, 2026	Lynx1 Capital Management LP45	10% Owner	Buy	520	$10.60	$5,512.00	-	-	-
Mar 10, 2026	Sandell Scott D55	10% Owner	Buy	207,100	$11.11	$2,300,881.00	+19.0%	-	-
Mar 10, 2026	Yang Rick	10% Owner	Buy	207,100	$11.11	$2,300,881.00	+19.0%	-	-
Mar 10, 2026	New Enterprise Associates 17, L.P.	10% Owner	Buy	207,100	$11.11	$2,300,881.00	+19.0%	-	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC